Lunai Bioworks Inc. (LNAI) Research

Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."

Market snapshot

Symbol
LNAI
Price
$3.78
Day change
-5.50%
Market cap
$17.1M
P/E ratio
-0.09x
52-week range
1.208-31.04
Sector
Healthcare
Industry
Biotechnology

Recent news

  • Lunai Bioworks (LNAI) Stock Is Trending Overnight — Here's Why It Spiked Nearly 81% In After-Hours Session

    Lunai Bioworks Inc. shares soared 80.88% after-hours after regaining Nasdaq compliance with minimum bid price requirements.

Peer companies

  • Adaptimmune Therapeutics plc (ADAP)
  • Adlai Nortye Ltd. (ANL)
  • Apollomics, Inc. (APLM)
  • BioLineRx Ltd. (BLRX)
  • Ernexa Therapeutics Inc. (ERNA)
  • GeoVax Labs, Inc. (GOVX)
  • SeaStar Medical Holding Corporation (ICU)
  • Lipocine Inc. (LPCN)

Open Lunai Bioworks Inc. (LNAI) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.